Our Portfolio.
AI Therapeutics utilises artificial intelligence to precisely match drugs to new disease indications, speeding up discovery and trials to provide the best care for patients.
Cleaflow’s technology advances healing in cardiac surgery by preventing post-operative complications associated with retained blood and fluid.
Hyperfine has developed the world’s first point-of-care MRI system, leveraging the million-fold improvement in compute power since the first MRI systems over 40 years ago.
Kit Check’s focus is helping pharmacists improve operational efficiency, patient safety, and medication visibility throughout the hospital.
PFS is a molecular diagnostics company that informs clinicians whether radiation therapy will benefit breast cancer patients.
Acquired by Exact Sciences Corp.
The first health insurance recommendation engine, tuned and tailored to the lives of individual consumers. Stride partners with the largest communities of freelancers and contractors to help them get the benefits they need.
Access Telehealth is a virtual clinic Telehealth provider of specialist care to Rural Australia, as well as offering NDIS and Aged Care solutions.
Butterfly Network is a digital health company that has pioneered the worlds first handheld whole-body ultrasound system.
Listed on the NYSE (BFLY)
Decipher is a precision oncology company providing information on the underlying biology of a patient's tumour, assisting the selection of optimal therapies.
Acquired by Veracyte Inc.
Jiff serves as a central hub for wellbeing and other benefit programs for Employers. Acquired by Castlight in 2017.
Leon’s focus is on delivering innovation in drug development through excellence in nano science.
Q-Si, the world’s first next-generation protein sequencing company, helping take medicine from DNA based insights through to the protein level.
Listed on the NASDAQ (QSI)
The eye is the window into the body.
Tesseract is building a portable, affordable device for monitoring and preventing disease.
CAIS is the leading alternative investment platform for financial advisors who seek improved access to and education about alternative investment funds and products.
Celsee is a single-cell analysis company, with applications including single-cell cytometry, proteogenomics, transcriptomics, and rare-cell enumeration. Acquired by Bio-Rad in 2020.
Detect is an at-home novel Nucleic Acid Test to power the next generation of viral and bacteria diagnostics.
Jump is a hospital supply chain and analytics company that automates the tracking of medical supplies.
Liminal is building a medical device to non-invasively measure key vital signs in the brain.
Sanguine uses mobile technology to solve complex clinical trial challenges, pioneering in-home specimen collection, a leader in direct-to-patient recruitment and digital health innovation.
AgBiome creates innovative and novel agricultural products, leveraging naturally occurring genetic variations from its proprietary microbial database.